Bolt Biotherapeutics, Inc.

Advance two pipeline programs toward IND-enabling development

Deadline not yet reached (430 days left)

Announced: 23 Oct 2026
Due: 31 Dec 2027

Deadline
Met
Late
Not met
Today

What the company said

“Two additional undisclosed pipeline programs are expected to advance toward IND-enabling development by the second half of 2027”

SourceBolt Biotherapeutics, Inc. Form 8-K press release, 2026-10-23
FilingSEC filing index
Deadline as statedby the second half of 2027
Deadline used31 Dec 2027, the last day of the stated period
TypeProduct
Permanent referenceKI-C-2026-BOLT-022897
Cite as https://keptindex.org/c/KI-C-2026-BOLT-022897/ — this address never changes.

What we found

The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 31 Dec 2027.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Product other
Indicative materiality: Low rules
Action: Advance
Deliverable: Two pipeline programs
Language: Expected (“expects”, “plans”)
In the company’s control: High
Specificity: High

Tell me what happens

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Alert me when this resolves

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Bolt Biotherapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2026-BOLT-022897 · Corrections policy